APPENDIX A – Media and Solution Preparation Appendix A
Regarding the present experimental research, a summary of recommended and standard aseptic
techniques should be fol owed throughout every procedure, to ensure axenic conditions.
Therefore al material in use should be sterilized by autoclaving (120ºC for 20 min), and al the
procedures performed on a sterile bench (disinfected with 70% alcohol). Most of the procedures should be performed in a wel -ventilated area.
Gloves, goggles and lab coats should be worn when working with chemicals. Nitrile gloves are
recommended when working with solvents and acids.
SOLUTIONS AMPICILLIN, KANAMYCIN, RIFAMPICIN AND TETRACYCLINE ANTIBIOTIC SOLUTIONS
Preparation of stock solutions for solid medium (e.g. Marine Agar) is recommended. The stock
solutions should be 100-300x the concentration of antibiotic required in the enriched medium.
Reagents (for a final concentration of 103 mg.L-1) Procedures Ampicil in & Kanamycin antibiotic solutions
C16H18N3NaO4S (Ampicil in sodium; Sigma Chemical Co.)
C18H36N4O11.H2SO4 (Kanamicin; Sigma Chemical Co.)
0.1 g 1. Weigh out 0.1 g of each antibiotic
C43H58N4O12 (Rifampicin; Sigma Chemical Co.)
C22H24N2O8 (Tetracycline; Sigma Chemical Co.)
pinch 2. Separately, dissolve the ampicil in
and kanamycin powders in 10 ml distil ed water. Mix very wel , so that al the antibiotic powder goes into solution (to the ampicil in solution, a pinch of NaOHa can be added so the pH is adjusted and
dissolution optimized); 3. Filter sterilise the solutions into sterile falcon tubes, using a syringe with an attached 0.2 µm filter sterilization unit; 4. Store the kanamycin solution at 4ºC and the rifampicin at -20ºC.
Rifampicin & Tetracycline antibiotic solutions 1. Dissolve the rifampicin powder per 10 ml of methanol and the tetracycline in another 10 ml of ethanol; 2. Transfer the solutions to separate sterile falcon tubes; 3. Wrap the falcon tubes in aluminium foil and immediately store them in the dark at -20ºC. a If using an acidic form of Ampicil in instead of the sodium salt form as indicated in these procedures, then no NaOH should be added.
Most antibiotic solutions wil remain stable for up to 3 months, if stored at 0°C. However, Rifampicin
should be freshly prepared for each use.
Stock solutions in water must be filter sterilized through a 0.2 µm pore filter. Antibiotics dissolved in
ethanol or methanol, do not need to be filter sterilized, since bacteria do not grow in such toxic
NINE-SALT SOLUTION – OLSSON et al. (1992) Reagents 1. Weigh out the reagents and place them in a 1 L volumetric flask;
2. Add 1000 ml of double-distil ed water and mix it very wel ;3. Pour into storage bottles and sterilize the solution by autoclaving
4. Al ow them to cool, and tighten the lids.
NEUTRAL BUFFERED FORMA LDEHYDE SOLUTION – HOPWOOD (1977)
Ten percent neutral buffered formaldehyde is the standard fixative used in most laboratories. It
preserves a wide range of tissues and requires a relatively short fixation time. However it can also be used for long-term storage, as it produces no deleterious effects on tissue morphology with nuclear and cytoplasmic detail being adequately preserved (Cleary et al., 2005).
1. Combine the sodium phosphate salts in 500 ml of distil ed water.
2. Adjust the pH to 7.0 with sodium phosphate concentrated stocks if Na2HPO4
necessary; 3. Make up to 1 L with the remaining distil ed water;
4. Filter the solution through a 0.45 µm pore filter and store it in a tightly capped, label ed bottle. Notes Formaldehyde is a known carcinogen and should be handled in such a way as to minimize
exposure (Cleary et al., 2005). It may irritate eyes and respiratory passages, and can cause skin and lung al ergy. It has also been reported to cause impaired memory and dexterity, and can be fatal if ingested (Sheehan et al., 1980).
Because of formaldehyde’s hazards, specific regulations should be implemented, regarding its safe
handling and storage. Safety precautions include proper ventilation and exhaust, as wel as limited or restricted exposure periods. At al times goggles, gloves and lab coat should be worn.
For 10% neutral buffered formaldehyde solution to be effective, the specimen has to be completely
submerged in five to ten times its volume of fixative.
This solution is usual y stable for 30 days. As a precaution, the pH of old solutions should be
checked (if acidic the solution shouldn’t be used).
PHOSPHATE-BUFFERED SALINE SOLUTION – SAMBROOK et al. (2001)
0.20 g 1. Weigh out the reagents for the selected total volume of PBS and
0.24 g place them in a volumetric flask;
drops 2. Add distil ed water to the required volume and mix it very wel .
Adjust to a 7.4 pH with HCl; 3. Dispense into storage bot les and sterilize the solution by autoclaving it at 120ºC for 15 minutes;
4. Al ow to cool, and then tighten the lids. HEPES FIX BASE
10.22 g 1. Dissolve al the reagents in 400 ml distil ed water, while
HEPESb (Sigma Chemical Co.) 17.85 g stirring; CaCl2.2H2O
3. Add distil ed water to bring the volume to 500 ml;
MODIFIED KARNOVSKY’S FIXATIVE
Karnovsky original y formulated this fixative as a sodium cacodylate-buffered, calcium chloride-
enhanced mixture of 5% glutaraldehyde and 4% formaldehyde (Karnovsky, 1965).
This original recipe produced a hypertonic medium (2010 mOsM) that was so hypertonic, that over
the years most investigators have chosen to change it for solutions at half-strength. Prepared without the calcium chloride, with a phosphate buffer rather than sodium cacodylate buffer, and various concentrations of formaldehyde and glutaraldehyde (Salema & Santos, 1992).
Massie et al. (1972) indicate that HEPPES buffer is a non-toxic substitute for bicarbonate buffers.
0.5 g 1. Under the laminar flow hood, bring 10 ml of distil ed
drops water to approximately 60ºC and add 0.5 g
HEPES fix base (mentioned above) 5 ml paraformaldehyde powder, while stirring;
7.9 ml 2. Add 2-3 drops of 2 N NaOH and stir the solution until it
b HEPES (N-2-ydroxyethylpiperazine-N’-2-ethane sulfonic acid), Code H3375 - Sigma Chemical Co.
clears; 3. After adding 5 ml of HEPES fix base solution, let the solution cool at room temperature;
4. Add the glutaraldehyde solution at pH 7.2-7.4 to bring the volume to 25 ml; 5. Store the solution at 4ºC.
Formadehyde, although a poor x-linker, penetrates tissue at about 5x the rate of glutaraldehyde. It
is thought that this fast penetration helps to stabilize the tissue structures that are later on stabilized further by the glutaraldehyde.
This fixative should not be kept for more than two weeks before use, because the formaldehyde
component wil begin repolymerizing into paraformaldehyde.
GROWTH AND TESTING MEDIA MARINE BROTH
The Marine Broth 2216 (Difco LaboratoriesTM; BD – Bioscience) is prepared according to the formula
of ZoBel . The media contains al of the nutrients necessary for the growth of heterotrophic marine
bacteria. It contains minerals that nearly duplicate the major mineral composition of seawater, in addition to peptone and yeast extract that provide a good source of nutrients (nitrogen, vitamins and minerals) -
Retrieved [20th March, 2006 at 12:57h], from Becton, Dickinson and Company (ht p:/ www.bd.com/ds/technicalCenter/inserts/
Procedure 1. Suspend 37.4 g of the Marine Broth (MB) dehydrated powder in 1 L of distil ed water. Mix thoroughly; 2. Heat under frequent agitation, and boil for 1 minute to completely dissolve the powder;
3. Transfer the media into 1 L bottles and autoclave them at 120ºC for 15 min; 4. Al ow the bottles to cool and tighten the lids. 10% MARINE AGAR
The high salt content from Marine Broth 2216 (Difco LaboratoriesTM; BD – Bioscience) helps to
simulate the sea water. For that reason when preparing 10% Marine Agar, NaCl was added.
Agar is the solidifying agent. Reagents
Marine Broth (2216 Difco Laboratories™)
Bacteriological Grade Agar (ICN Biomedicals)
Procedure 1. Suspend the MB dehydrated powder in 1 L distil ed water. Heat to the boiling point;
2. Add NaCl and the bacteriological grade agar, while stirring with a magnet. Let it boil for 1 minute to optimize dissolution; 3. Transfer the media into 2 L bottles. Screw on the caps loosely, and autoclave the bottles for 15 minutes at 120ºC and 15 lb/sq. in.;
4. After autoclaving, vigorously swirl the solutions in the bottles, al owing the molten agar to mix; 5. Al ow the media to cool down to 50ºC (when one can hold the bot om of the flask for 10-20 s); 6. Under a laminar flow hood pour the media into sterile plastic Petri dishes (approximately 25 ml for 90 mm Petri dishes). If bubbles appear on the surface of the agar, they may be removed by briefly
flaming the surface with a Bunsen burner; 7. After pouring, leave the dishes dry for 15-20 min (while stil inside the laminar flow); 8. Store the Petri dishes facing down (inverted position)c in sealed “tape-shut” plastic sleeves, and
incubate them overnight at 20ºC; 9. On the fol owing days check for growth of bacterial contaminants. After selection, keep them stored in an incubator at room temperature. Notes To prepare Marine Agar medium supplemented with antibiotics (MA+R+A), Ampicil in and
Rifampicin from proper sterile antibiotic stock solutions, should be added, until 10 mg.L-1 of each are obtained in the final plates volume. When transferring the antibiotics, aseptic procedures should be fol owed.
The sterilized agar should be cooled to 50ºC, before the addition of heat-sensitive antibiotics (e.g.
YEAST EXTRACT-PEPTONE-DEXTROSE Complex media containing a homogenous blend of Peptone, Yeast Extract and D-Glucose in
optimal concentration, is used for maintaining and propagating most Saccharomyces cerivisiae strains and other yeast.
The addition of protein and yeast extract hydrolysates al ows a faster growth during the exponential
or log-phase growth – Retrieved [30th April, 2007 at 08:33h], from Becton, Dickinson and Company (http://www.bd.com/ds/technicalCenter/inserts/YPD_Agar.pdf).
The Bacteriological Grade Agar works as the solidifying agent in solid YEPD mediums. c So that any moisture that may occur, wil be col ected on the top of the plate without flooding the bottom where bacteria wil grow.
Yeast Extract (Thermo Fisher Scientific Inc.)
Bacteriological Grade Agar (MP Biomedicals Co.)
Procedure 1. Weigh out the appropriate reagents and place them into a flask at least 2 times larger than the
media volume; 2. Suspend al reagents (with exception of the D-Glucose) in 950 ml of distil ed water, and gently bring to the boiling point, al owing it to dissolve completely; 3. Sterilise the agar and broth media by autoclaving at 120ºC for 15 minutes;
4. Al ow the media to cool down to 50ºC, and aseptical y add D-Glucose to 2% (50 ml previously autoclaved). Mix thoroughly and adjust the final volume (1 L) if necessary. Notes
Liquid YEPD medium is ready for use. With solid medium, gently pour the molten agar into sterile
Petri dishes, as described in previous procedures.
Yeast extract and peptone provide carbon, nitrogen, minerals, vitamins, trace ingredients and other
essential growth nutrients. The yeast extract further supplies vitamin B-complexes, which stimulate the growth of yeasts and bacteria. Dextrose (D-Glucose) is the carbohydrate source.
If adding supplements such as amino acid mixtures, care should be taken to avoid agar hydrolysis.
Supplements should be added after autoclaving.
YEAST NITROGEN BASED MEDIUM
Yeast Nitrogen Base Y1250 (Sigma Chemical Co.)
Procedure 1. Suspend the reagents in 1 litter of distil ed water;
2. Heat with frequent agitation and boil for 1 minute to completely dissolve the powder; 3. Dispense into suitable containers and autoclave at 120ºC for 15 minutes; 4. Al ow the bottles to cool and tighten the lids.
Press release – 26 May 2004 Omega Pharma acquires a portfolio of OTC and personal care brands from Pfizer Nazareth (Belgium) – 26 May 2004 – Omega Pharma has agreed to acquire a portfolio of 60 European OTC and personal care brands from Pfizer for cash consideration of €135 million (approximately $US163 million). The transaction is expected to be completed at or shortly afte
Safety evaluation of a recombinant myxoma-RHDV virusinducing horizontal transmissible protection against myxomatosisJuan M. Torresa,*, Miguel A. RamõÂreza, MoÂnica Moralesa, Juan BaÂrcenaa,BeleÂn VaÂzqueza, Enric EspunÄab, Albert PageÁs-ManteÂb, Jose M. SaÂnchez-VizcaõÂnoaaCentro de InvestigacioÂn en Sanidad Animal (CISA-INIA), Valdeolmos, 28130 Madrid, SpainReceived 14 Feb